Literature DB >> 7757920

Fructosamine concentrations in hyperglycemic cats.

T A Lutz1, J S Rand, E Ryan.   

Abstract

The aims of this study were 1) to establish a reference range for fructosamine in cats using a commercial fructosamine kit; 2) to demonstrate that the fructosamine concentration is not increased by transient hyperglycemia of 90 min duration, simulating hyperglycemia of acute stress; and 3) to determine what percentage of blood samples submitted to a commercial laboratory from 95 sick cats had evidence of persistent hyperglycemia based on an elevated fructosamine concentration. Reference intervals for the serum fructosamine concentration were established in healthy, normoglycemic cats using a second generation kit designed for the measurement of the fructosamine concentration in humans. Transient hyperglycemia of 90 min duration was induced by IV glucose injection in healthy cats. Multisourced blood samples that were submitted to a commercial veterinary laboratory either as fluoride oxalated plasma or serum were used to determine the percentage of hyperglycemic cats having persistent hyperglycemia. The reference interval for the serum fructosamine concentration was 249 to 406 mumol/L. Transient hyperglycemia of 90 min duration did not increase the fructosamine concentration and there was no correlation between fructosamine and blood glucose. In contrast, the fructosamine concentration was correlated with the glucose concentration in sick hyper- and normoglycemic cats. It is concluded that the fructosamine concentration is a useful marker for the detection of persistent hyperglycemia and its differentiation from transient stress hyperglycemia. Fructosamine determinations should be considered when blood glucose is 12 to 20 mmol/L and only a single blood sample is available for analysis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7757920      PMCID: PMC1686902     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  9 in total

1.  [Fructosamine as a valuable criterion for the evaluation of diabetic animals and its photometric determination].

Authors:  G Staudacher
Journal:  Tierarztl Prax       Date:  1990-10

2.  Effect of protein concentration on the formation of glycated albumin and fructosamine.

Authors:  E Lamb; R Mainwaring-Burton; A Dawnay
Journal:  Clin Chem       Date:  1991-12       Impact factor: 8.327

3.  Influence of serum albumin & total protein on fructosamine measurement.

Authors:  B S Das; S K Satpathy; S Mohanty; T K Bose
Journal:  Indian J Med Res       Date:  1992-02       Impact factor: 2.375

4.  Serum fructosamine concentrations in patients with type II (non-insulin-dependent) diabetes mellitus during changes in management.

Authors:  J R Baker; R N Johnson; D J Scott
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-19

5.  Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control.

Authors:  R N Johnson; P A Metcalf; J R Baker
Journal:  Clin Chim Acta       Date:  1983-01-07       Impact factor: 3.786

6.  The use of plasma fructosamine in the assessment of diabetic control.

Authors:  B O Saeed; N M elWali; G S Atabani; E M Elmahdi; E Mukhtar
Journal:  Trop Geogr Med       Date:  1991 Jan-Apr

7.  Correction of fructosamine value for serum albumin and globulin concentrations.

Authors:  K Kunika; M Itakura; K Yamashita
Journal:  Diabetes Res Clin Pract       Date:  1991-08       Impact factor: 5.602

8.  Clinical validation of a second-generation fructosamine assay.

Authors:  W T Cefalu; A D Bell-Farrow; M Petty; C Izlar; J A Smith
Journal:  Clin Chem       Date:  1991-07       Impact factor: 8.327

9.  Use of protein-based standards in automated colorimetric determinations of fructosamine in serum.

Authors:  J R Baker; P A Metcalf; R N Johnson; D Newman; P Rietz
Journal:  Clin Chem       Date:  1985-09       Impact factor: 8.327

  9 in total
  6 in total

1.  Effect of acute hyperglycaemia on the serum fructosamine and blood glycated haemoglobin concentrations in canine samples.

Authors:  M C Marca; A Loste; J J Ramos
Journal:  Vet Res Commun       Date:  2000-02       Impact factor: 2.459

2.  Study of the effect of total serum protein and albumin concentrations on canine fructosamine concentration.

Authors:  A Loste; M C Marca
Journal:  Can J Vet Res       Date:  1999-04       Impact factor: 1.310

3.  Plasma amylin and insulin concentrations in normoglycemic and hyperglycemic cats.

Authors:  T A Lutz; J S Rand
Journal:  Can Vet J       Date:  1996-01       Impact factor: 1.008

Review 4.  Obesity in rhesus and cynomolgus macaques: a comparative review of the condition and its implications for research.

Authors:  Sharon A Bauer; Tara P Arndt; Ken E Leslie; David L Pearl; Patricia V Turner
Journal:  Comp Med       Date:  2011-12       Impact factor: 0.982

5.  Serum glycated albumin: Potential use as an index of glycemic control in diabetic dogs.

Authors:  T Sako; A Mori; P Lee; T Sato; H Mizutani; T Takahashi; Y Kiyosawa; H Tazaki; T Arai
Journal:  Vet Res Commun       Date:  2008-12-03       Impact factor: 2.459

Review 6.  Managing feline diabetes: current perspectives.

Authors:  Susan Gottlieb; Jacquie Rand
Journal:  Vet Med (Auckl)       Date:  2018-06-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.